all frequency decisions are made by the prescribing physician Administration Subcutaneous injection for systemic wound healing, post-surgical recovery, and combination protocols
Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y
Key Dates Include: Pre-release: December 4, 2024 Open for proposal submissions: January 8, 2025 DSIP Topic Q&A Closure: January 22, 2025, at 10:00 AM MT Close for proposal submissions: February 5, 2025, at 10:00 AM MT Participating DoD Components: Department of the Navy (Navy) Department of the Air Force (Air Force) Defense Health Agency (DHA) Missile Defense Agency (MDA) For further details on active topics and the submission process, you can explore the DoDs SBIR/STTR portal here
Common combinations include Epithalon with CJC/Ipamorelin for patients targeting both sleep and body composition, Epithalon with GHK-Cu for patients focused on cellular repair and skin quality alongside longevity support, and Epithalon with MOTS-c for patients on metabolic and mitochondrial optimization protocols
